BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//InvisionCommunity Events 4.7.23//EN
METHOD:PUBLISH
CALSCALE:GREGORIAN
REFRESH-INTERVAL:PT15M
X-PUBLISHED-TTL:PT15M
X-WR-CALNAME:Community Calendar
NAME:Community Calendar
BEGIN:VTIMEZONE
TZID:Europe/London
TZURL:http://tzurl.org/zoneinfo/Europe/London
X-LIC-LOCATION:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T020000Z
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T020000Z
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
SUMMARY:Veracuity: Innovative approaches to drug safety
DTSTAMP:20210121T170759Z
SEQUENCE:0
UID:379-1-ee2a5ec9cbd1b5a75b4ec5d63ec903ec@www.pslhub.org
ORGANIZER;CN="Sam":noreply@pslhub.org
DESCRIPTION:\n	Veracuity was conceived out of a recognition that the pra
	ctice of pharmacovigilance is performed suboptimally. That is because it r
	elies entirely on a voluntary reporting system – one in which consumers 
	and healthcare professionals must devote considerable energy if they were 
	so inclined to notify somebody about a side effect they attribute to a bio
	-pharmaceutical product. Adverse event reporting is infrequent and cumbers
	ome because stakeholders are only vaguely aware of their responsibility an
	d the current system is neither easy nor fast to use. Nor does it provide 
	reporters with any immediate helpful feedback. With only a very small perc
	entage of adverse drug events ever reaching the attention of manufacturers
	 or regulators\, it is easy to conclude that the medical community and the
	 public may be wholly unaware of tremendous risks and liabilities that may
	 be attributed to drug products.\n\n\n\n	This workshop allows participati
	on in insightful conversation on the future of our industry.\n\n\n\n		Prog
	ram: Fishbein\, J: Introduction and closing remarks. \n	\n	\n		Barrett\, 
	CP: Implementation of Post-marketing Risk Management Commitment.\n	\n	\n		
	Laugel\, I: The future of pharmacovigilance with the use of artificial int
	elligence sounds good. \n	\n	\n		Marschler\, M: The use of pharmacogenomi
	c methodologies in the pharmacovigilance evaluation of medicinal products.
	\n	\n\n	This webinar meets two times.\n\n\n\n		Fri\, Jan 29\, 2021 12:00 P
	M - 2:00 PM GMT\n	\n	\n		Fri\, Jan 29\, 2021 6:00 PM - 8:00 PM GMT\n	\n\n	
	Register\n\n2021-workshop-flier.pdf
DTSTART;VALUE=DATE:20210129
END:VEVENT
END:VCALENDAR